Status in the House for the 91st Legislature (2019 - 2020)
Insulin products sold in Minnesota cost review authorized by commissioner of health, excessive cost determined, maximum level of reimbursement established for insulin products if necessary, and money appropriated.
01/22/2019 | |
01/24/2019 |
Authors added Loeffler and Dehn
pg.
120
|
03/11/2019 |
Committee report, to adopt as amended and re-refer to Health and Human Services Policy
pg.
937a
|
03/13/2019 |
Committee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
pg.
1013
|
03/20/2019 |
Author added Persell
pg.
1510
|
04/01/2019 |
Author added Bierman
pg.
1785
|